The posting
About the Company We’re an early-stage, venture-backed AI company (Series A, backed by top healthcare and AI investors) building software for pharma and biotech regulatory teams. Our platform helps regulatory affairs and medical writing groups produce the documents that drug approvals depend on. That work has traditionally taken large teams weeks of manual drafting and review. We were founded a few years ago by a team that previously built and led a clinical research technology company. We’re...



